Drug Profile
Suritozole
Alternative Names: MDL 26479Latest Information Update: 21 Dec 1999
Price :
$50
*
At a glance
- Originator Aventis
- Class Antidepressants; Neuroprotectants; Nootropics
- Mechanism of Action GABA A receptor inverse agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease; Major depressive disorder
Most Recent Events
- 21 Dec 1999 Discontinued-II for Alzheimer's disease in USA (Unknown route)
- 21 Dec 1999 Discontinued-II for Depression in United Kingdom (Unknown route)
- 21 Dec 1999 Discontinued-II for Depression in USA (Unknown route)